R&D Systems, Minneapolis, MN) in RPMI-1640 (Gibco, Detroit, MI) medium supplemented with 2% penicillin/streptomycin (Gibco), 20 mM HEPES (Gibco) and 5% pooled normal human heat-inactivated and sterile-filtered AB serum (Innovative Research, Novi, MI) for 7 days, with a media change on day 5 with fresh M-CSF (10 ng/mL)
permit a pharmacy to begin compounding immediately
Reporting suspected adverse reactions helps the MHRA monitor the safety of medicines and substances used in the UK
Athira failed to disclose allegations of research misconduct to the National Institutes of Health in grant applications that referenced the manipulated papers, including a grant NIH funded in 2019
Thereby, the subsequent burn studies were on the burns covering 20% of total body area on the back of mice, open flame for 5 or 7 s (Mikus et al., 2001